OrbiMed’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-131,653
Closed -$1.27M 156
2019
Q4
$1.27M Sell
131,653
-9,056
-6% -$87.1K 0.02% 124
2019
Q3
$1.49M Sell
140,709
-366,762
-72% -$3.89M 0.03% 105
2019
Q2
$5.84M Hold
507,471
0.09% 98
2019
Q1
$6.5M Buy
+507,471
New +$6.5M 0.1% 95